agilon health inc
NYSE:AGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
agilon health inc
NYSE:AGL
|
US |
|
FBR Ltd
ASX:FBR
|
AU |
|
Exor NV
AEX:EXO
|
NL |
|
A
|
ABx Group Ltd
ASX:ABX
|
AU |
|
Deep Medicine Acquisition Corp
NASDAQ:TRUG
|
US |
|
Cipla Ltd
NSE:CIPLA
|
IN |
|
Netcompany Group A/S
CSE:NETC
|
DK |
|
D
|
Dunxin Financial Holdings Ltd
AMEX:DXF
|
CN |
|
Sanofi SA
MIL:1SAN
|
FR |
|
E
|
EVO Payments Inc
F:E19
|
US |
|
E
|
Erawan Group PCL
SET:ERW
|
TH |
|
A
|
Aida Engineering Ltd
TSE:6118
|
JP |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of AGL.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
AGL Competitors Multiples
agilon health inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
agilon health inc
NYSE:AGL
|
164.3m USD | 0 | -0.3 | 0.3 | 0.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
89.1B USD | 0.2 | 50.4 | 13.3 | 13.3 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.6B EUR | 0.3 | 13 | 7.7 | 9.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
69B USD | 0.2 | 11.4 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
25.1B EUR | 1.1 | 19.9 | 9.4 | 14 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.8B EUR | 1.1 | 23 | 8.9 | 16.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.6 | 24.7 | 11.9 | 17.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.5B USD | 2 | 22 | 11.9 | 16 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 0.6 | 11.1 | 5.3 | 9.9 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.1B USD | 11.4 | -26.9 | -29.5 | -26.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 0.8 | 14 | 7.2 | 9.8 |